Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Brought to you by:
Biotech
Lilly inks deals to buy 3 vaccine developers for up to $3.8B
Lilly is acquiring Curevo, LimmaTech and Vaccine Company to extend its shopping spree into viral and bacterial pathogen R&D.
Nick Paul Taylor
May 26, 2026 7:57am
Lilly preps gene editor for ph. 2 after strong cholesterol cuts
May 25, 2026 8:45am
Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?
May 22, 2026 8:28am
Liminatus pays $320M in stock for CAR-T biotech InnocsAI
May 21, 2026 8:09am
Sanofi, Wave post updates in race to end AATD’s 40-year drought
May 18, 2026 4:30pm
Create Medicines fashions $122M raise for in vivo CAR-T dreams
May 14, 2026 9:42am
